Engineered immune cells take on lupus in first human test

NCT ID NCT06333483

Ongoing Disease control Sponsor: Autolus Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This early-phase trial is testing a one-time treatment called obecabtagene autoleucel (obe-cel) for people with severe lupus that hasn't improved with standard treatments. Obe-cel is made by taking a patient's own immune cells, engineering them to target and attack faulty B cells, and giving them back after a short course of chemotherapy. The main goals are to see if the treatment is safe and tolerable, and to get an early look at whether it can put lupus into remission. Only 18 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: obecabtagene autoleucel (obe-cel), a CAR T-cell therapy made from the patient's own immune cells
What this could lead to: If it works, this could point toward a new treatment option for people with severe lupus that hasn't responded to other therapies.
What could go wrong: This is a very early Phase 1 trial with only 18 participants, so it's mainly checking safety. The treatment may not work, and there are risks like severe immune reactions or side effects from the chemotherapy used beforehand.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Locations

Addenbrookes Hospital

Cambridge, CB2 0QQ, United Kingdom
Great Ormond Street Hospital

London, WC1N 3JH, United Kingdom
Hospital Universitari Vall Hebrón

Barcelona, 08035, Spain
Hospital Universitari i Politecnic La Fe

Valencia, 106046026, Spain
Manchester Royal Infirmary, Manchester University NHS Foundation Trust,

Manchester, M13 9WL, United Kingdom
University College London Hospitals NHS Foundation Trust

London, NW1 2PG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.